Work

A phase 2 multimodality trial of docetaxel/prednisone with sunitinib followed by salvage radiation therapy (RT) in men with PSA recurrent prostate cancer (PC) after radical prostatectomy (RP).

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.7_suppl.35

Authors: Andrew J. Armstrong, Susan Halabi, Patrick Healy, Robert Lee, Bridget F. Koontz, Judd W. Moul, Kelly Mundy, Patricia Creel, Sarah Yenser Wood, Kristen Davis, Brooke Reimer, Minh Nguyen, Avery N. Spitz, Ellen Bratt, Sung Kim, Phuoc T. Tran, Mark N. Stein, Michael Anthony Carducci, Daniel J. George

Institutions: Duke University, Duke Medical Center, Duke Cancer Institute, University of North Carolina at Chapel Hill, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Rutgers Cancer Institute

Language: English

Topic: Prostate Cancer Diagnosis and Treatment

Subfield: Urology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2210173698

Cites:

Cited by:

Related to: 10